## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_20 at 10.1% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($436.09)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Levi & Korsinsky Notifies Synopsys, Inc. (SNPS) Shareholders of Class Action Lawsuit and December 30, 2025 Deadline**
- Source: KTSM 9 News | 20251207T160807 | Neutral | Relevance: 99%
-  Levi & Korsinsky LLP has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of shareholders who experienced losses between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made false statements regarding the negative impact of its increased focus on AI customers on its Design IP business economics. Shareholders are encouraged to learn about their rights to seek recovery, with a deadline to join the lawsuit by December 30, 2025.

**2. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: WOODTV.com | 20251206T230848 | Neutral | Relevance: 99%
-  The Rosen Law Firm reminds investors who purchased Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024, and September 9, 2025, of the December 30, 2025, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Synopsys made materially false and misleading statements about its business operations and prospects, specifically regarding the negative impact of its increased focus on artificial intelligence customers on its Design IP business. Investors who suffered damages are encouraged to join the class action.

**3. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: FOX40 News | 20251207T110857 | Neutral | Relevance: 99%
-  The Rosen Law Firm is reminding purchasers of Synopsys, Inc. (NASDAQ: SNPS) securities who bought between December 4, 2024, and September 9, 2025, that the lead plaintiff deadline for a securities fraud lawsuit is December 30, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business operations, particularly concerning the impact of increased focus on AI customers on its Design IP business economics. Investors who suffered losses are encouraged to contact the Rosen Law Firm to explore their options to join the class action.

**4. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: WWLP | 20251206T230855 | Neutral | Relevance: 99%
-  The Rosen Law Firm reminds investors who purchased Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024, and September 9, 2025, of the December 30, 2025 lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Synopsys failed to disclose how its increased focus on AI customers was negatively impacting its Design IP business economics and financial results. Investors are encouraged to contact the firm to potentially lead the class action.

**5. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: PIX11 | 20251207T170841 | Neutral | Relevance: 99%
-  The Rosen Law Firm is reminding purchasers of Synopsys, Inc. (NASDAQ: SNPS) securities that they have until December 30, 2025, to seek appointment as lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Synopsys made materially false and misleading statements regarding the negative impact of its increased focus on AI customers on its Design IP business and financial results. Investors who purchased Synopsys securities during the Class Period (December 4, 2024, to September 9, 2025) may be eligible for compensation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | B of A Securiti | $500 | $525 | -5% |
| 2025-12-03 | Keybanc | $575 | $590 | -3% |
| 2025-11-25 | Wells Fargo | $445 | $550 | -19% |
| 2025-11-24 | Citigroup | $580 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | B of A Securiti | up | Neutral |
| 2025-12-03 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-24 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.69M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation risk: PEG 6.2x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 6.18 signals overvaluation risk, limited margin of safety. Forward P/E 33.1x stretched relative to 9% growth. Quality metrics strong (margin 31%). Revenue growth strong at 37% YoY. Analyst sentiment negative (3 target cuts vs 0 raises). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $88.8B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.18 |
| Forward P/E | 33.1 |
| Current P/E | 36.3 |
| YoY Growth | 9.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at 10.1% (minimal 5-day change). Extended beyond STRENGTH zone (10.1% > 10.0%), caution on chasing. MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 12.3% shows strong absolute momentum above own 20MA. Outperforming sector by 8.9pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (10.48), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 10.08% (CS: 95) | Strong |
| RSI_14 | 67.2 | Neutral |
| MACD Histogram | 10.48 | Bullish |
| vs SMA20 | 1.123x | Above |
| vs SMA50 | 1.063x | Above |
| vs SMA200 | 0.954x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $465.75
- **Stop Loss:** $436.09 (6.4% risk)
- **Target:** $495.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 40
- **Position Value:** $18,630.00
- **Portfolio %:** 18.63%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2025-12-10 (Est: $2.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |
| 2024Q4 | $3.30 | $3.40 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*